CY1114609T1 - METHODS OF CANCER TREATMENT USING P13K ALPHA PYRIDOPYRIMIDINONIS - Google Patents

METHODS OF CANCER TREATMENT USING P13K ALPHA PYRIDOPYRIMIDINONIS

Info

Publication number
CY1114609T1
CY1114609T1 CY20131100805T CY131100805T CY1114609T1 CY 1114609 T1 CY1114609 T1 CY 1114609T1 CY 20131100805 T CY20131100805 T CY 20131100805T CY 131100805 T CY131100805 T CY 131100805T CY 1114609 T1 CY1114609 T1 CY 1114609T1
Authority
CY
Cyprus
Prior art keywords
pyridopyrimidinonis
alpha
methods
cancer treatment
cancer
Prior art date
Application number
CY20131100805T
Other languages
Greek (el)
Inventor
Peter Lamb
David Matthews
Original Assignee
Exelixis, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08742677.1A external-priority patent/EP2139484B9/en
Application filed by Exelixis, Inc. filed Critical Exelixis, Inc.
Publication of CY1114609T1 publication Critical patent/CY1114609T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μεθόδους θεραπείας καρκίνου με χορήγηση Ένωσης του Τύπου Ι, προαιρετικώς ως φαρμακευτικώς αποδεκτό άλας, διαλύτωμα ή/και υδρίτη αυτής, σε συνδυασμό με άλλες θεραπείες καρκίνου.The present invention provides methods of treating cancer by administering a Compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and / or hydrate thereof, in combination with other cancer therapies.

CY20131100805T 2007-04-10 2013-09-18 METHODS OF CANCER TREATMENT USING P13K ALPHA PYRIDOPYRIMIDINONIS CY1114609T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92289907A 2007-04-10 2007-04-10
EP08742677.1A EP2139484B9 (en) 2007-04-10 2008-04-09 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha

Publications (1)

Publication Number Publication Date
CY1114609T1 true CY1114609T1 (en) 2016-10-05

Family

ID=58448820

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100805T CY1114609T1 (en) 2007-04-10 2013-09-18 METHODS OF CANCER TREATMENT USING P13K ALPHA PYRIDOPYRIMIDINONIS

Country Status (1)

Country Link
CY (1) CY1114609T1 (en)

Similar Documents

Publication Publication Date Title
CY1114608T1 (en) Combination therapies including quinoxaline P3K alpha inhibitor for use in cancer therapy
CY1120417T1 (en) METHODS TO REDUCE BASEFLOW LEVELS
EA200970932A1 (en) METHODS OF TREATMENT WITH THE APPLICATION OF PYRIDOPYRIMIDINONOVES INHIBITORS PI3K ALPHA
CY1124298T1 (en) FENFLURAMINE FOR USE IN THE THERAPEUTIC TREATMENT OF DRAVET SYNDROME
CY1125144T1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF THERAPY AND USE THEREOF
TR201900306T4 (en) Methods of using Mek inhibitors.
EA201270247A1 (en) METHODS OF APPLICATION OF C-METER-MODULATORS
CY1121735T1 (en) FOR USE IN THE TREATMENT OF CANCER
CY1121882T1 (en) PYRAZOLYL QUINOXALINE KINASE INHIBITORS
CY1124000T1 (en) SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM
EA201390085A1 (en) COMPOSITIONS OF KINAZ INHIBITORS FOR CANCER TREATMENT
CY1119676T1 (en) COMPOSITIONS AND METHODS FOR CANCER TREATMENT
CY1118227T1 (en) PHARMACEUTICAL PROPERTIES OF PHARMACEUTICAL PROPERTIES
CY1119227T1 (en) Pyridine derivatives as mild ROCK inhibitors
CY1121628T1 (en) SALTS IT AND METHODS OF USE
CY1116007T1 (en) Imidazo compound [4,5-C] quinolin-2-one and its use as a dual P13 kinase inhibitor / mTOR
EA201490194A1 (en) COMBINED THERAPY, INCLUDING CDK4 / 6 INHIBITOR AND PI3K INHIBITOR FOR USE IN CANCER TREATMENT
CY1121334T1 (en) MOVEMENT INHIBITOR AURORA A
CY1114735T1 (en) THERAPEUTIC COMPOSITIONS CONTAINING A SPECIFIC COMPONENT OF THE ENDOTHINAL CONCENTRATOR AND A PDE5 INSPECTOR
CY1117831T1 (en) Combination Therapy For Breast Cancer Therapeutic Treatment
CY1123614T1 (en) METHOD OF TREATMENT OF DYSKIKINA
CY1116216T1 (en) METHOD OF THERAPEUTIC DISEASE THERAPY
EA201490199A1 (en) THERAPEUTIC WAYS
EA201590347A1 (en) AZHETEROCYCLES AS BIR2 AND / OR BIR3 INHIBITORS
CY1114609T1 (en) METHODS OF CANCER TREATMENT USING P13K ALPHA PYRIDOPYRIMIDINONIS